Literature DB >> 25182472

Assessment of final product dosing accuracy when using volumetric technique in the preparation of chemotherapy.

Lindsey B Poppe1, Scott W Savage1, Stephen F Eckel2.   

Abstract

BACKGROUND: Studies have compared gravimetric and volumetric dosing accuracies in chemotherapy agents, finding high accuracy in gravimetric measurements with a mean deviation of ± 0.06%, while volumetric measurements had a mean deviation of ± 3.02%.
METHODS: Chemotherapy doses prepared under a biological safety cabinet containing two weights from the precision scale between 15 December 2010 and 30 March 2011 were eligible for inclusion. Empty syringes attached to a closed-system transfer device were weighed prior to product manipulation. The product was then prepared using the syringe pull-back method (volumetric technique) and the same syringe containing drug was weighed (gravimetric method).
RESULTS: A total of 1156 compounded sterile products were eligible for the study. The mean percent volume difference of preparations included was -0.53% with a range of -64.9% to 94.22% for individual doses. Of the prepared doses, 71.7% were within ± 5% and 87.4% were within ± 10% of the ordered dose. Secondary outcomes found to be associated with an increased percent volume difference were the pediatric population, smaller volumes prepared, drugs requiring reconstitution compared to already in solution, and final product dispensed to the patient in syringes.
CONCLUSION: While the mean value of volumetric measurements is within the generally understood acceptable range for dispensing chemotherapy, the range of measurements is highly variable. Future studies are warranted to better understand the reasons behind the variation and to evaluate the impact of workflow changes on improving final product accuracy.
© The Author(s) 2014.

Entities:  

Keywords:  Chemotherapy; accuracy; gravimetric; precision; volumetric

Mesh:

Substances:

Year:  2014        PMID: 25182472      PMCID: PMC9345624          DOI: 10.1177/1078155214549489

Source DB:  PubMed          Journal:  J Oncol Pharm Pract        ISSN: 1078-1552            Impact factor:   1.416


  9 in total

1.  Occurrence and impact of unanticipated variation in intravenous methotrexate dosing.

Authors:  Christopher S Parshuram; L Lee Dupuis; Teresa To; Sheila S Weitzman; Gideon Koren; Andreas Laupacis
Journal:  Ann Pharmacother       Date:  2006-04-25       Impact factor: 3.154

2.  Telepharmacy and bar-code technology in an i.v. chemotherapy admixture area.

Authors:  Brian C O'Neal; John C Worden; Rick J Couldry
Journal:  Am J Health Syst Pharm       Date:  2009-07-01       Impact factor: 2.637

3.  Accuracy and reproducibility of syringe measurements.

Authors:  S N Lee; A H Wong; A Mayer; S E Walker
Journal:  Am J Health Syst Pharm       Date:  1996-05-15       Impact factor: 2.637

4.  Safety in the preparation of cytotoxic drugs: How to integrate gravimetric control in the quality assurance policy?

Authors:  J Lecordier; Y Heluin; C Plivard; A Bureau; C Mouawad; B Chaillot; J-J Lahet
Journal:  Biomed Pharmacother       Date:  2011-01-05       Impact factor: 6.529

5.  Electronic balance as quality assurance for cytotoxic drug admixtures.

Authors:  H Ritter; L A Trissel; R W Anderson; L M Moyer; J S Morales
Journal:  Am J Health Syst Pharm       Date:  1996-10-01       Impact factor: 2.637

6.  Observational study of accuracy in compounding i.v. admixtures at five hospitals.

Authors:  E A Flynn; R E Pearson; K N Barker
Journal:  Am J Health Syst Pharm       Date:  1997-04-15       Impact factor: 2.637

7.  Impact of robotic antineoplastic preparation on safety, workflow, and costs.

Authors:  Andrew C Seger; William W Churchill; Carol A Keohane; Caryn D Belisle; Stephanie T Wong; Katelyn W Sylvester; Megan A Chesnick; Elisabeth Burdick; Matt F Wien; Michael C Cotugno; David W Bates; Jeffrey M Rothschild
Journal:  J Oncol Pract       Date:  2012-09-25       Impact factor: 3.840

8.  Discrepancies between ordered and delivered concentrations of opiate infusions in critical care.

Authors:  Christopher S Parshuram; Geraldine Y T Ng; Tommy K L Ho; Julia Klein; Aideen M Moore; Desmond Bohn; Gideon Koren
Journal:  Crit Care Med       Date:  2003-10       Impact factor: 7.598

9.  How to calculate the dose of chemotherapy.

Authors:  Howard Gurney
Journal:  Br J Cancer       Date:  2002-04-22       Impact factor: 7.640

  9 in total
  3 in total

1.  Pharmacokinetic and pharmacodynamic bioequivalence between regular human insulin (rDNA origin) in 0.9% sodium chloride ready-to-use infusion 1 U/mL and 100 U/mL concentrate diluted to 1 U/mL in healthy males.

Authors:  Marcus Hompesch; Aleksandra Hawryluk; Moises Hernandez; Beena Uchil; Alyssa Wilmington; Lucas Peterson
Journal:  Diabetes Obes Metab       Date:  2021-09-08       Impact factor: 6.408

2.  Intravenous Chemotherapy Compounding Errors in a Follow-Up Pan-Canadian Observational Study.

Authors:  Rachel E Gilbert; Melissa C Kozak; Roxanne B Dobish; Venetia C Bourrier; Paul M Koke; Vishal Kukreti; Heather A Logan; Anthony C Easty; Patricia L Trbovich
Journal:  J Oncol Pract       Date:  2018-04-20       Impact factor: 3.840

3.  Impact of technology-assisted versus manual sterile compounding on safety and efficiency in a Canadian community hospital.

Authors:  Mark Fan; Danny Yang; Becky Ng; Jocelyn Jackson; Katherine Bouris; Sharon Eng; Edith Rolko; Patricia Trbovich
Journal:  Am J Health Syst Pharm       Date:  2022-09-22       Impact factor: 2.980

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.